Search Results - Sh. F. Erdes
- Showing 1 - 20 results of 136
- Go to Next Page
-
1
THE NEW VERSION OF T2T (TREAT-TO-TARGET) FOR SPONDYLOARTHRITIDES by Sh. F. Erdes
Published 2017-10-01
Article -
2
THE POSSIBILITIES AND RESULTS OF INDIRECT COMPARISON OF BIOLOGICAL AGENTS IN ANKYLOSING SPONDYLITIS by Sh. F. Erdes
Published 2016-12-01
Article -
3
Features of the course and outcomes of COVID-19 in patients with axial spondyloarthritis by Sh. F. Erdes
Published 2022-07-01
Article -
4
PROBLEMS OF SPONDYLOARTHRITIS IN THE PROCEEDINGS OF THE EULAR-2013 CONGRESS (MADRID, 12–15 JUNE 2013) by Sh. F. Erdes
Published 2014-06-01
Article -
5
A NEW CONCEPT OF SPONDYLOARTHRITIS: A COMPROMISE BETWEEN ASAS AND GRAPPA? by Sh. F. Erdes
Published 2018-01-01
Article -
6
-
7
The abilities of golimumab in the therapy of ankylosing spondylitis by Sh. F. Erdes
Published 2014-09-01
Article -
8
INTERLEUKIN-17A IS A NEW TARGET OF ANTICYTOKINE THERAPY FOR ANKYLOSING SPONDYLITIS by Sh. F. Erdes
Published 2016-09-01
Article -
9
-
10
-
11
UPDATED ASAS-EULAR GUIDELINES FOR AXIAL SPONDYLOARTHRITIS by Sh. F. Erdes
Published 2016-12-01
Article -
12
«TREAT-TO-TARGET» (T2T) STRATEGY IN SPONDYLOARTHRITIS by Sh. F. Erdes
Published 2014-06-01
Article -
13
Recent advances and prospects of axial spondyloarthritis / ankylosing spondylitis treatment by Sh. F. Erdes
Published 2021-04-01
Article -
14
CERTOLIZUMAB PEGOL IN THE TREATMENT OF AXIAL SPONDYLOARTHRITIS by Sh. F. Erdes
Published 2016-02-01
Article -
15
DEFINITION OF THE TERM «RHEUMATOLOGY»: DO WE NEED THIS AND HOW DO THE EULAR AND THE ACR LOOK AT THIS? by Sh. F. Erdes
Published 2018-07-01
Article -
16
SPONDYLOARTHRITIS: EVOLUTION OF A CONCEPT by Sh. F. Erdes
Published 2014-10-01
Article -
17
-
18
-
19
-
20
DIFFICULTIES IN THE DIAGNOSIS OF DIFFUSE IDIOPATHIC SKELETAL HYPEROSTOSIS (FORESTIER'S DISEASE) by A. S. Starkova, Sh. F. Erdes
Published 2016-09-01
Article